BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 23708210)

  • 1. Adapting clinical paradigms to the challenges of cancer clonal evolution.
    Murugaesu N; Chew SK; Swanton C
    Am J Pathol; 2013 Jun; 182(6):1962-71. PubMed ID: 23708210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumor diversity and clonal evolution in cancer--a skeptical standpoint.
    Gisselsson D
    Adv Cancer Res; 2011; 112():1-9. PubMed ID: 21925299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic analysis of tumor clonality.
    Teixeira MR; Heim S
    Adv Cancer Res; 2011; 112():127-49. PubMed ID: 21925303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment.
    Apostoli AJ; Ailles L
    Crit Rev Clin Lab Sci; 2016; 53(1):40-51. PubMed ID: 26397062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-Evaluating Clonal Dominance in Cancer Evolution.
    Burrell RA; Swanton C
    Trends Cancer; 2016 May; 2(5):263-276. PubMed ID: 28741512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal evolution models of tumor heterogeneity.
    Shlush LI; Hershkovitz D
    Am Soc Clin Oncol Educ Book; 2015; ():e662-5. PubMed ID: 25993239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development.
    Dzobo K; Senthebane DA; Thomford NE; Rowe A; Dandara C; Parker MI
    OMICS; 2018 Jan; 22(1):17-34. PubMed ID: 29356626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenges of tumor genetic diversity.
    Mroz EA; Rocco JW
    Cancer; 2017 May; 123(6):917-927. PubMed ID: 27861749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapies of solid cancers: new options, new challenges.
    Awada A; Aftimos PG
    Curr Opin Oncol; 2013 May; 25(3):296-304. PubMed ID: 23493191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumor heterogeneity: nature and biological significance.
    Gerashchenko TS; Denisov EV; Litviakov NV; Zavyalova MV; Vtorushin SV; Tsyganov MM; Perelmuter VM; Cherdyntseva NV
    Biochemistry (Mosc); 2013 Nov; 78(11):1201-15. PubMed ID: 24460935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The origins of cancer robustness and evolvability.
    Tian T; Olson S; Whitacre JM; Harding A
    Integr Biol (Camb); 2011 Jan; 3(1):17-30. PubMed ID: 20944865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine.
    Hiley C; de Bruin EC; McGranahan N; Swanton C
    Genome Biol; 2014 Aug; 15(8):453. PubMed ID: 25222836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumor heterogeneity: origins, clinical significance and optimal strategies for cancer treatment.
    Mangano A; Lianos GD; Mangano A; Boni L; Dionigi G
    Future Oncol; 2015; 11(4):561-4. PubMed ID: 25686113
    [No Abstract]   [Full Text] [Related]  

  • 14. Clonal evolution in cancer.
    Greaves M; Maley CC
    Nature; 2012 Jan; 481(7381):306-13. PubMed ID: 22258609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumor heterogeneity in epigenetic patterns.
    Assenov Y; Brocks D; Gerhäuser C
    Semin Cancer Biol; 2018 Aug; 51():12-21. PubMed ID: 29366906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concerns about targeting cancer stem cell for cancer therapy.
    Yang G; Lu X; Fu H; Jin L; Yao L; Lu Z
    Med Hypotheses; 2011 Mar; 76(3):457. PubMed ID: 21288650
    [No Abstract]   [Full Text] [Related]  

  • 17. Deciphering intratumor heterogeneity using cancer genome analysis.
    Ryu D; Joung JG; Kim NK; Kim KT; Park WY
    Hum Genet; 2016 Jun; 135(6):635-42. PubMed ID: 27126234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenge of intratumour heterogeneity in precision medicine.
    Seoane J; De Mattos-Arruda L
    J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells with genetic instability: the best vehicle with the best engine for cancer.
    Lagasse E
    Gene Ther; 2008 Jan; 15(2):136-42. PubMed ID: 17989699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution.
    Gupta RG; Somer RA
    Mol Cancer Res; 2017 Sep; 15(9):1127-1137. PubMed ID: 28596419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.